eFFECTOR Therapeutics (FRA:LWK) Ending Cash Position : €14.27 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is eFFECTOR Therapeutics Ending Cash Position?

eFFECTOR Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 was €14.27 Mil.

eFFECTOR Therapeutics's quarterly Ending Cash Position increased from Sep. 2023 (€5.05 Mil) to Dec. 2023 (€13.64 Mil) and increased from Dec. 2023 (€13.64 Mil) to Mar. 2024 (€14.27 Mil).

eFFECTOR Therapeutics's annual Ending Cash Position declined from Dec. 2021 (€43.99 Mil) to Dec. 2022 (€8.22 Mil) but then increased from Dec. 2022 (€8.22 Mil) to Dec. 2023 (€13.64 Mil).

eFFECTOR Therapeutics Ending Cash Position Historical Data

The historical data trend for eFFECTOR Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

eFFECTOR Therapeutics Ending Cash Position Chart

eFFECTOR Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

12.51

43.99

8.22

13.64

eFFECTOR Therapeutics Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial										9.63	13.58	5.05	13.64	14.27

eFFECTOR Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

eFFECTOR Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7.984	+	5.656
	=	13.64

eFFECTOR Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	13.685	+	0.582
	=	14.27

eFFECTOR Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of eFFECTOR Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

eFFECTOR Therapeutics (FRA:LWK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

EFTR:USA LWK:Germany

Address

142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075

Website

https://www.effector.com

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

eFFECTOR Therapeutics (FRA:LWK) Headlines

No Headlines